P Conesa-Zamora

Summary

Country: Spain

Publications

  1. ncbi Role of cell cycle biomarkers in human papillomavirus related uterine lesions
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetics Group, Pathology Department, Santa Lucía General University Hospital, C Mezquita s n 30202, Cartagena, Spain
    Curr Pharm Des 19:1412-24. 2013
  2. doi Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetic Group, Pathology Department, Santa Lucía General University Hospital HGUSL, 30202 Cartagena, Spain Catholic University of Murcia UCAM, 30107 Murcia, Spain Electronic address
    Gynecol Oncol 131:480-8. 2013
  3. doi Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetic Group, Santa Lucía General University Hospital HUGSL, 30202 Cartagena, Spain Electronic address
    Exp Mol Pathol 95:151-5. 2013
  4. pmc Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
    Pablo Conesa-Zamora
    Pathology Department, Santa Lucía General University Hospital HGUSL, 30202, Cartagena, Spain
    BMC Cancer 13:228. 2013
  5. doi Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma
    Pablo Conesa-Zamora
    Department of Pathology, Santa Lucía General University Hospital, Cartagena, Spain
    Int J Cancer 132:297-307. 2013
  6. ncbi Analysis of performance characteristics of five cell cycle-related immunohistochemical markers and human papillomavirus genotyping in the diagnosis of cervical squamous cell carcinoma precursor lesions
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetics Group, Department of Internal Medicine, Santa María del Rosell University Hospital, Cartagena, Spain
    Anal Quant Cytol Histol 34:49-55. 2012
  7. pmc Comparison of allelic discrimination by dHPLC, HRM, and TaqMan in the detection of BRAF mutation V600E
    Pablo Carbonell
    Biochemistry and Clinical Genetic Center, Virgen Arrixaca University Hospital, Murcia, Spain
    J Mol Diagn 13:467-73. 2011
  8. doi Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma
    P Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética, Hospital Universitario SM Rosell HUSMR, Cartagena, Spain
    Hum Immunol 71:314-7. 2010
  9. pmc Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain
    Pablo Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética FFIS011, Hospital Universitario Santa María del Rosell, Cartagena, Spain
    BMC Infect Dis 9:124. 2009
  10. doi Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix
    P Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética, Hospital Universitario Santa María del Rosell, Cartagena, Spain
    J Clin Pathol 62:159-62. 2009

Collaborators

  • Miguel Pérez-Guillermo
  • J Corral
  • Ana Conesa
  • J Ruiz-Cosano
  • J Garcia-Solano
  • Pablo Carbonell
  • Adriana Ordonez
  • D Torres-Moreno
  • E Rodriguez-Braun
  • P Carbonell
  • I Pagán-Gómez
  • D Torres-Moreno D
  • J Trujillo-Santos
  • José García-Solano
  • Daniel Torres-Moreno
  • María C Turpín
  • Irene Molina-Martínez
  • Soren R Kristensen
  • Antonia Minano
  • Shona Pedersen
  • Ole Thorlacius-Ussing
  • Vicente Vicente
  • Jose Yelamos
  • Irene Martínez-Martínez
  • Mogens T Stender

Detail Information

Publications13

  1. ncbi Role of cell cycle biomarkers in human papillomavirus related uterine lesions
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetics Group, Pathology Department, Santa Lucía General University Hospital, C Mezquita s n 30202, Cartagena, Spain
    Curr Pharm Des 19:1412-24. 2013
    ....
  2. doi Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetic Group, Pathology Department, Santa Lucía General University Hospital HGUSL, 30202 Cartagena, Spain Catholic University of Murcia UCAM, 30107 Murcia, Spain Electronic address
    Gynecol Oncol 131:480-8. 2013
    ....
  3. doi Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetic Group, Santa Lucía General University Hospital HUGSL, 30202 Cartagena, Spain Electronic address
    Exp Mol Pathol 95:151-5. 2013
    ....
  4. pmc Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study
    Pablo Conesa-Zamora
    Pathology Department, Santa Lucía General University Hospital HGUSL, 30202, Cartagena, Spain
    BMC Cancer 13:228. 2013
    ..EPHX1, NQO1 and PON1 are three genes encoding proteins directly involved in the detoxification of potential carcinogens...
  5. doi Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma
    Pablo Conesa-Zamora
    Department of Pathology, Santa Lucía General University Hospital, Cartagena, Spain
    Int J Cancer 132:297-307. 2013
    ..Molecular profiling demonstrates that SAC shows activation of distinct signaling pathways and that immunohistochemical fascin1 and hippocalcin expression can be reliably used for its differentiation from other CRC subtypes...
  6. ncbi Analysis of performance characteristics of five cell cycle-related immunohistochemical markers and human papillomavirus genotyping in the diagnosis of cervical squamous cell carcinoma precursor lesions
    Pablo Conesa-Zamora
    Molecular Pathology and Pharmacogenetics Group, Department of Internal Medicine, Santa María del Rosell University Hospital, Cartagena, Spain
    Anal Quant Cytol Histol 34:49-55. 2012
    ....
  7. pmc Comparison of allelic discrimination by dHPLC, HRM, and TaqMan in the detection of BRAF mutation V600E
    Pablo Carbonell
    Biochemistry and Clinical Genetic Center, Virgen Arrixaca University Hospital, Murcia, Spain
    J Mol Diagn 13:467-73. 2011
    ..dHPLC could detect four non-V600E mutations, whereas HRM detected one. Our results indicate that dHPLC and HRM are techniques that can be reliably used for the detection of the BRAFV600E mutation in archival paraffin-embedded tissues...
  8. doi Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma
    P Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética, Hospital Universitario SM Rosell HUSMR, Cartagena, Spain
    Hum Immunol 71:314-7. 2010
    ....
  9. pmc Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain
    Pablo Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética FFIS011, Hospital Universitario Santa María del Rosell, Cartagena, Spain
    BMC Infect Dis 9:124. 2009
    ....
  10. doi Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix
    P Conesa-Zamora
    Grupo de Patología Molecular y Farmacogenética, Hospital Universitario Santa María del Rosell, Cartagena, Spain
    J Clin Pathol 62:159-62. 2009
    ....
  11. doi Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas
    J Garcia-Solano
    Department of Pathology, Santa Lucía General University Hospital HGUSL, C Mezquita s n, 30202 Cartagena, Spain
    Int J Cancer 131:1790-9. 2012
    ..0003, p < 0.0001, p < 0.0001, p < 0.001, respectively). SACs are more often KRAS-mutated and microsatellite stable and display different molecular and immunohistochemical characteristics compared to CC and sMSI-H...
  12. doi Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody
    Adriana Ordonez
    Centro Regional de Hemodonacion, University of Murcia, Spain
    Thromb Haemost 104:1143-9. 2010
    ..This result explains the absence of association of this marker with an increased risk of thrombosis in patients with colorectal adenocarcinoma...
  13. ncbi Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population
    J Ruiz-Cosano
    Molecular Pathology and Pharmacogenetic Group Pathology Department, Santa Lucía General University Hospital HGUSL, Cartagena, Spain
    J BUON 18:486-90. 2013
    ..Herein we performed a case-control study evaluating the influence of three single nucleotide polymorphisms (SNPs) in XPA, ERCC5 and MTR [rs1800975 (G-4A), rs17655 (Asp1104His) and rs1805087 (A2756G), respectively] in lymphoma risk...